InvestorsHub Logo

Whalatane

09/13/20 5:28 PM

#20356 RE: Uncle Gee Gee #20344

UGG. thx for the contact info

To Brian Korb....bkorb@troutgroup.com

Dear Sir , I understand you handle information requests for NeuroRx .
I'm an investor in Relief Therapeutics , NeuroRx is running their Covid trials for RLF-100 in the US .

Can you please ask them to update investors re the status of the IV RLF-100 trial.
1) Are they having an Interim 2 DMC analysis ?
2) Is this trial fully enrolled ...in which case ...estimated read out time ?
3) Clinical trials.gov lists this trial as a P 2 trial whereas Co's media / Dr Javitt refers to it as P 2b/3. Can you ask the Co to clarify ?
Thankyou in advance for your help



I'll post any response .
Kiwi